Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies
The DOI matches its Crossref record; 117 of the 119 references it cites were found in a registry or an index.
Abstract
In human immunodeficiency virus (HIV)-infected patients, Pneumocystis jirovecii pneumonia (PCP) is a well-known opportunistic infection, and its management has been established. However, PCP is an emerging threat to immunocompromised patients without HIV infection, such as those receiving novel immunosuppressive therapeutics for malignancy, organ transplantation, or connective tissue diseases. Clinical manifestations of PCP are quite different between patients with and without HIV-infections. In patients without HIV infection, PCP rapidly progresses, is difficult to diagnose correctly, and causes severe respiratory failure with a poor prognosis. High-resolution computed tomography findings are different between PCP patients with HIV infection and those without. These differences in clinical and radiologic features are the result of severe or dysregulated inflammatory responses that are evoked by a relatively small number of Pneumocystis organisms in patients without HIV infection. In recent years, the usefulness of PCR and serum β-D-glucan assay for rapid and noninvasive diagnosis of PCP has been revealed. Although corticosteroid adjunctive to anti-Pneumocystis agents has been shown to be beneficial in some populations, the optimal dose and duration remain to be determined. Recent investigations revealed that Pneumocystis colonization is prevalent, and that asymptomatic carriers are at riskfor developing PCP and can serve as the reservoir for the spread of Pneumocystis by person-to-person transmission. These findings suggest the need for chemoprophylaxis in immunocompromised patients without HIV infection, although its indication and duration are still controversial. Because a variety of novel immunosuppressive therapeutics have been emerging in medical practice, further innovations in the diagnosis and treatment of PCP are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, the increasing use of immunosuppressant drugs, their use in high doses or their combination has increased numbers of PCP cases in patients with solid tumours, haematological malignancies, rheumatic diseases or organ transplant recipients [128,129].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [128]
In the citing paper
“As this microorganism cannot be cultured in laboratory conditions, direct examination and immunofluorescence are used as reference methods with sensitivity rates higher than 90% [128,131], or PCR methods in developed countries [132].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [128]
Citations
Cites
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Kasiske, B. L., Zeier, M. G., Chapman, J. R., Craig, J. C., Ekberg, H., Garvey, C. A., Green, M. D., Jha, V., Josephson, M. A., Kiberd, B. A., et al. (2010) · Kidney International · doi:10.1038/ki.2009.377 · Cited by 1,735
Kaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009) · PsycEXTRA Dataset · doi:10.1037/e537722009-001 · Cited by 1,343
Thomas, C. F., & Limper, A. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032588 · Cited by 1,037
KOVACS, J. A., HIEMENZ, J. W., MACHER, A. M., STOVER, D., MURRAY, H. W., SHELHAMER, J., LANE, H. C., URMACHER, C., HONIG, C., LONGO, D. L., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-663 · Cited by 855
Phair, J., Muñoz, A., Detels, R., Kaslow, R., Rinaldo, C., Saah, A., & the Multicenter AIDS Cohort Study Group* (1990) · New England Journal of Medicine · doi:10.1056/nejm199001183220304 · Cited by 684
Yale, S. H., & Limper, A. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.5 · Cited by 644
(2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70002-4 · Cited by 607
Limper, A. H., Offord, K. P., Smith, T. F., & Martin, W. J. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.5.1204 · Cited by 494
A New Name for Pneumocystis from Humans and New Perspectives on the Host-Pathogen Relationship
Stringer, J. R., Beard, C. B., Miller, R. F., & Wakefield, A. E. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0809.020096 · Cited by 490
Pneumocystis carinii Infection: Evidence for High Prevalence in Normal and Immunosuppressed Children
Pifer, L. L., Hughes, W. T., Stagno, S., & Woods, D. (1978) · Pediatrics · doi:10.1542/peds.61.1.35 · Cited by 434
Takeuchi, T., Tatsuki, Y., Nogami, Y., Ishiguro, N., Tanaka, Y., Yamanaka, H., Kamatani, N., Harigai, M., Ryu, J., Inoue, K., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.072967 · Cited by 402
Green, H., Paul, M., Vidal, L., & Leibovici, L. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.9.1052 · Cited by 379
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis
Lapraik, C., Watts, R., Bacon, P., Carruthers, D., Chakravarty, K., D’Cruz, D., Guillevin, L., Harper, L., Jayne, D., Luqmani, R., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem146a · Cited by 369
Prevention and Treatment of Cancer-Related Infections
Baden, L. R., Bensinger, W., Angarone, M., Casper, C., Dubberke, E. R., Freifeld, A. G., Garzon, R., Greene, J. N., Greer, J. P., Ito, J. I., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0146 · Cited by 368
Onishi, A., Sugiyama, D., Kogata, Y., Saegusa, J., Sugimoto, T., Kawano, S., Morinobu, A., Nishimura, K., & Kumagai, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05267-11 · Cited by 328
Pneumocystis carinii Pneumonia Among Patients Without AIDS at a Cancer Hospital
Sepkowitz, K. A. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480060078034 · Cited by 323
Current insights into the biology and pathogenesis of Pneumocystis pneumonia
Thomas, C. F., & Limper, A. H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1621 · Cited by 275
Serum Indicators for the Diagnosis of Pneumocystis Pneumonia
Tasaka, S., Hasegawa, N., Kobayashi, S., Yamada, W., Nishimura, T., Takeuchi, T., & Ishizaka, A. (2007) · Chest · doi:10.1378/chest.06-1467 · Cited by 263
Self-citationPneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.
Godeau, B., Coutant-Perronne, V., Huong, D. U. L. T., Guillevin, L., Magadur, G., Bandt, M. D., Dellion, S., Rossert, J., Rostoker, G., & Pietté, J. C. (1994) · PubMed · Cited by 254
Rituximab-Associated Infections
Gea-Banacloche, J. C. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.01.002 · Cited by 251
Pneumocystis jirovecii Pneumonia
Catherinot, E., Lanternier, F., Bougnoux, M.-E., Lecuit, M., Couderc, L.-J., & Lortholary, O. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.10.010 · Cited by 248
Epidemiology and Clinical Significance of Pneumocystis Colonization
Morris, A., Wei, K., Afshar, K., & Huang, L. (2008) · The Journal of Infectious Diseases · doi:10.1086/523814 · Cited by 248
Serologic Responses to Pneumocystis carinii Antigens in Health and Disease
Peglow, S. L., Smulian, A. G., Linke, M. J., Pogue, C. L., Nurre, S., Crisler, J., Phair, J., Gold, J. W. M., Armstrong, D., & Walzer, P. D. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.2.296 · Cited by 235
Pneumocystis jirovecii in General Population
Medrano, F. J., Montes-Cano, M., Conde, M., de la Horra, C., Respaldiza, N., Gasch, A., Perez-Lozano, M. J., Varela, J. M., & Calderon, E. J. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1102.040487 · Cited by 232
Use of Adjunctive Corticosteroids in Severe Adult Non-HIV Pneumocystis carinii Pneumonia
Pareja, J. G., Garland, R., & Koziel, H. (1998) · Chest · doi:10.1378/chest.113.5.1215 · Cited by 223
Pneumocystis jiroveci (carinii) Pneumonia After Infliximab Therapy: A Review of 84 Cases
Kaur, N., & Mahl, T. C. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9250-x · Cited by 217
F., R., C., G., Moal, G. L., B., G., Souala, M. F., M., D., Gentile, L. D., J., G., Y., G., C., L., et al. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0758-5 · Cited by 210
Ognibene, F. P., Shelhamer, J. H., Hoffman, G. S., Kerr, G. S., Reda, D., Fauci, A. S., & Leavitt, R. Y. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.3.7881673 · Cited by 210
Ward, M. M., & Donald, F. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<780::aid-anr23>3.0.co;2-m · Cited by 206
Signal transduction and transcription factors in rheumatic disease
Firestein, G. S., & Manning, A. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<609::aid-anr3>3.0.co;2-i · Cited by 198
Clinical Picture of Pneumocystis jiroveci Pneumonia in Cancer Patients
Bollée, G., Sarfati, C., Thiéry, G., Bergeron, A., de Miranda, S., Menotti, J., de Castro, N., Tazi, A., Schlemmer, B., & Azoulay, É. (2007) · Chest · doi:10.1378/chest.07-0223 · Cited by 192
HIV-Associated Pneumocystis Pneumonia
Huang, L., Cattamanchi, A., Davis, J. L., Boon, S. D., Kovacs, J., Meshnick, S., Miller, R. F., Walzer, P. D., Worodria, W., & Masur, H. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201009-062wr · Cited by 191
Flori, P., Bellete, B., Durand, F., Raberin, H., Cazorla, C., Hafid, J., Lucht, F., & Sung, R. T. M. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45528-0 · Cited by 191
Maskell, N. A. (2003) · Thorax · doi:10.1136/thorax.58.7.594 · Cited by 190
The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung.
Limper, A. H., Hoyte, J. S., & Standing, J. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119384 · Cited by 188
Obayashi, T., Negishi, K., Suzuki, T., & Funata, N. (2008) · Clinical Infectious Diseases · doi:10.1086/588295 · Cited by 183
Azoulay, É., Bergeron, A., Chevret, S., Bele, N., Schlemmer, B., & Menotti, J. (2009) · Chest · doi:10.1378/chest.08-1309 · Cited by 182
Evolving Health Effects of Pneumocystis: One Hundred Years of Progress in Diagnosis and Treatment
Kovacs, J. A., & Masur, H. (2009) · JAMA · doi:10.1001/jama.2009.880 · Cited by 179
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
KOIKE, T., HARIGAI, M., INOKUMA, S., INOUE, K., ISHIGURO, N., RYU, J., TAKEUCHI, T., TANAKA, Y., YAMANAKA, H., FUJII, K., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080791 · Cited by 179
Pneumocystis carinii Pneumonia Without Acquired Immunodeficiency Syndrome: More Patients, Same Risk
Sepkowitz, K. A., Brown, A. E., & Armstrong, D. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.11.1125 · Cited by 178
Update on the diagnosis and treatment of Pneumocystis pneumonia
Carmona, E. M., & Limper, A. H. (2011) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810380102 · Cited by 174
DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia
Wakefield, A. E., Guiver, L., Miller, R. F., & Hopkin, J. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)93062-e · Cited by 173
Pneumocystis Colonization Is Highly Prevalent in the Autopsied Lungs of the General Population
Ponce, C. A., Gallo, M., Bustamante, R., & Vargas, S. L. (2010) · Clinical Infectious Diseases · doi:10.1086/649868 · Cited by 165
Pneumocystis carinii pneumonia: spectrum of parenchymal CT findings.
Kuhlman, J. E., Kavuru, M., Fishman, E. K., & Siegelman, S. S. (1990) · Radiology · doi:10.1148/radiology.175.3.2343118 · Cited by 162
Komano, Y., Harigai, M., Koike, R., Sugiyama, H., Ogawa, J., Saito, K., Sekiguchi, N., Inoo, M., Onishi, I., Ohashi, H., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24283 · Cited by 156
Self-citationVassallo, R., Standing, J. E., & LIMPER, A. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3755 · Cited by 154
de Boer, M. G. J., Bruijnesteijn van Coppenraet, L. E. S., Gaasbeek, A., Berger, S. P., Gelinck, L. B. S., van Houwelingen, H. C., van den Broek, P., Kuijper, E. J., Kroon, F. P., & Vandenbroucke, J. P. (2007) · Clinical Infectious Diseases · doi:10.1086/513198 · Cited by 154
Huang, L., Morris, A., LIMPER, A. H., Beck, J. M., & Participants, O. B. O. T. A. P. W. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-015ms · Cited by 153
Radisic, M., Lattes, R., Chapman, J. F., Rial, M. D. C., Guardia, O. E., Seu, F., Gutierrez, P., Goldberg, J. C., & Casadei, D. H. (2003) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2003.00018.x · Cited by 142
Fujii, T., Iwamoto, A., Nakamura, T., Iwamoto, A., Iwamoto, A., & Iwamoto, A. (2007) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0484-5 · Cited by 141
Quist, J., & Hill, A. R. (1995) · CHEST Journal · doi:10.1378/chest.108.2.415 · Cited by 136
Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools
Reid, A. B., Chen, S. C.-A., & Worth, L. J. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834cac17 · Cited by 134
Pneumocystisinfection in humans: diagnosis and treatment
Calderón, E. J., Rivero, S. G., Durand-Joly, I., & Dei‐Cas, E. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.42 · Cited by 132
Álvarez-Martínez, M. J., Miró, J. M., Valls, M. E., Moreno, A., Rivas, P. V., Solé, M., Benito, N., Domingo, P., Muñoz, C., Rivera, E., et al. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.03.010 · Cited by 124
Huggett, J. F., Taylor, M. S., Kocjan, G., Evans, H. E., Morris-Jones, S., Gant, V, Novak, T., Costello, A. M., Zumla, A., & Miller, R. F. (2007) · Thorax · doi:10.1136/thx.2007.081687 · Cited by 124
Prevention and Treatment of Cancer-Related Infections
_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0013 · Cited by 124
Yazaki, H., Goto, N., Uchida, K., Kobayashi, T., Gatanaga, H., & Oka, S. (2009) · Transplantation · doi:10.1097/tp.0b013e3181aed389 · Cited by 117
Schmoldt, S., Schuhegger, R., Wendler, T., Huber, I., Söllner, H., Hogardt, M., Arbogast, H., Heesemann, J., Bader, L., & Sing, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02016-07 · Cited by 117
Latency is not an inevitable outcome of infection with Pneumocystis carinii
Chen, W., Gigliotti, F., & Harmsen, A. G. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5406-5409.1993 · Cited by 117
Matsumura, Y., Shindo, Y., Iinuma, Y., Yamamoto, M., Shirano, M., Matsushima, A., Nagao, M., Ito, Y., Takakura, S., Hasegawa, Y., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-76 · Cited by 112
Pneumocystis Pneumonia in Solid Organ Transplant Recipients
Martin, S. I., & Fishman, J. A. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02914.x · Cited by 112
Delclaux, C., Zahar, J.-R., Amraoui, G., Leleu, G., Lebargy, F., Brochard, L., Schlemmer, B., & Brun-Buisson, C. (1999) · Clinical Infectious Diseases · doi:10.1086/598651 · Cited by 111
Ribes, J. A., Limper, A. H., Espy, M. J., & Smith, T. F. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.4.830-835.1997 · Cited by 111
The Japanese experience with biologic therapies for rheumatoid arthritis
Takeuchi, T., & Kameda, H. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.154 · Cited by 108
Hardak, E., Brook, O. R., & Yigla, M. (2010) · Lung · doi:10.1007/s00408-009-9214-y · Cited by 107
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily
Sillaber, C., Herrmann, H., Bennett, K., Rix, U., Baumgartner, C., Böhm, A., Herndlhofer, S., Tschachler, E., Superti‐Furga, G., Jäger, U., et al. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02206.x · Cited by 106
Helweg-Larsen, J., Benfield, T., Atzori, C., & Miller, R. F. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp372 · Cited by 102
Update on the epidemiology and transmission of Pneumocystis carinii
Morris, A., Beard, C. B., & Huang, L. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(01)01514-3 · Cited by 101
Tokuda, H., Sakai, F., Yamada, H., Johkoh, T., Imamura, A., Dohi, M., Hirakata, M., Yamada, T., Kamatani, N., Kikuchi, Y., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0702 · Cited by 100
Self-citationPrognostic Value of Interleukin-8 in AIDS-Associated Pneumocystis Carinii Pneumonia
Benfield, T., Vestbo, J., Junge, J., Nielsen, T. L., Jensen, A. B., & Lundgren, J. D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697231 · Cited by 97
Enomoto, T., Azuma, A., Kohno, A., Kaneko, K., Saitô, H., Kametaka, M., Usuki, J., Gemma, A., Kudoh, S., & Nakamura, S. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01660.x · Cited by 96
Watanabe, T., Yasuoka, A., Tanuma, J., Yazaki, H., Honda, H., Tsukada, K., Honda, M., Gatanaga, H., Teruya, K., Kikuchi, Y., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605579 · Cited by 96
Mutations of Pneumocystis jirovecii Dihydrofolate Reductase Associated with Failure of Prophylaxis
Nahimana, A., Rabodonirina, M., Bille, J., Francioli, P., & Hauser, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4301-4305.2004 · Cited by 96
Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis.
Godeau, B., Mainardi, J., Roudot‐Thoraval, F., HACHULLA, E., Guillevin, L., Dû, L. T. H., Jarrousse, B., Remy, P., Schaeffer, A., & Pietté, J. C. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.12.991 · Cited by 95
Matsumura, Y., Ito, Y., Iinuma, Y., Yasuma-Mitobe, K., Yamamoto, M., Matsushima, A., Nagao, M., Takakura, S., & Ichiyama, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03605.x · Cited by 93
Nevez, G., Raccurt, C. P., Jounieaux, V., Dei‐Cas, E., & Mazars, E. (1999) · AIDS · doi:10.1097/00002030-199903110-00020 · Cited by 93
Torres, H. A., Chemaly, R. F., Storey, R. E., Aguilera, E. A., Nogueras, G. M., SAFDAR, A. Y. E. S. H. A., Rolston, K. V. I., RAAD, I. I., & Kontoyiannis, D. P. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0149-4 · Cited by 92
(1→3)β-d-Glucan Assay Positivity in Patients with Pneumocystis (carinii) jiroveci Pneumonia
Marty, F. M., Koo, S., Bryar, J., & Baden, L. R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00018 · Cited by 91
Tasaka, S., Tokuda, H., Sakai, F., Fujii, T., Tateda, K., Johkoh, T., Ohmagari, N., Ohta, H., Araoka, H., Kikuchi, Y., et al. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2871 · Cited by 90
Self-citationCurrent Understanding of Pneumocystis Immunology
Kelly, M. N., & Shellito, J. E. (2009) · Future Microbiology · doi:10.2217/fmb.09.116 · Cited by 89
Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients with Connective Tissue Diseases
Wananuwat, P., Suwannalai, P., Sungkanuparph, S., Limsuwan, T., Ngamjanyaporn, P., & Janwityanujit, S. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.05.004 · Cited by 87
Moon, S. M., Kim, T., Sung, H., Kim, M., Kim, S., Choi, S., Jeong, J., Woo, J. H., Kim, Y. S., & Lee, S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00669-11 · Cited by 85
Kameda, H., Tokuda, H., Sakai, F., Johkoh, T., Mori, S., Yoshida, Y., Takayanagi, N., Taki, H., Hasegawa, Y., Hatta, K., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4508 · Cited by 78
Self-citationRoths, J. B., Marshall, J. D., Allen, R. D., Carlson, G. A., & Sidman, C. L. (1990) · PubMed · Cited by 76
Pneumocystis jirovecii pneumonia in kidney transplantation
Goto, N., & Oka, S. (2011) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00691.x · Cited by 74
Keely, S. P., & Stringer, J. R. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.11.2745-2747.1997 · Cited by 74
de Boer, M. G. J., Gelinck, L. B. S., van Zelst, B. D., van de Sande, W. W. J., Willems, L. N. A., van Dissel, J. T., de Jonge, R., & Kroon, F. P. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.10.007 · Cited by 73
Pneumocystis Colonization in HIV‐Infected Patients
Huang, L., Crothers, K. A., Morris, A., Groner, G., Fox, M., Turner, J. R., Merrifield, C., Eiser, S., Zucchi, P., & Beard, C. B. (2003) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2003.tb00651.x · Cited by 72
Mori, S., Cho, I., & Sugimoto, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081270 · Cited by 72
Performance of a PCR Assay for Detection of Pneumocystis carinii from Respiratory Specimens
Caliendo, A. M., Hewitt, P. L., Allega, J., Keen, A., Ruoff, K. L., & Ferraro, M. J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.979-982.1998 · Cited by 72
Briel, M., Boscacci, R., Furrer, H., & Bucher, H. C. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-101 · Cited by 71
Castro, N. D., Xu, F., Porcher, R., Pavie, J. R., Molina, J., & Péraldi, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03143.x · Cited by 68
S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia
Skelly, M. J., Hoffman, J., Fabbri, M., Holzman, R. S., Clarkson, A. B., & Merali, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12984-4 · Cited by 67
FUJISAWA, T., SUDA, T., MATSUDA, H., INUI, N., NAKAMURA, Y., SATO, J., TOYOSHIMA, M., NAKANO, Y., YASUDA, K., GEMMA, H., et al. (2009) · Respirology · doi:10.1111/j.1440-1843.2008.01457.x · Cited by 62
Wollner, A., Mohle‐Boetani, J. C., Lambert, R. E., Perruquet, J. L., Raffin, T. A., & McGuire, J. L. (1991) · Thorax · doi:10.1136/thx.46.3.205 · Cited by 57
Fulminant Pneumocystis carinii Pneumonia in 4 Patients With Dermatomyositis
Bachelez, H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440340145015 · Cited by 57
Helweg‐Larsen, J., Lee, C., Jin, S., Hsueh, J. Y.-C., Benfield, T., Hansen, J. E., Lundgren, J. D., & Lundgren, B. (2001) · AIDS · doi:10.1097/00002030-200103090-00003 · Cited by 55
MEKINIAN, A., Durand-Joly, I., Hatron, P., Moranne, O. P., Denis, G., Dei‐Cas, E., Morell‐Dubois, S., Lambert, M., Launay, D., Delhaès, L., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq314 · Cited by 55
Pneumocystis jirovecii colonization in patients treated with infliximab
Wissmann, G., Morilla, R., Martín-Garrido, I., Friaza, V., RESPALDIZA, N., Povedano, J. M., Praena‐Fernández, J. M., Montes‐Cano, M. A., Medrano, F. J., Goldani, L. Z., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02415.x · Cited by 52
Manoloff, E. S., Francioli, P., Taffé, P., van Melle, G., Bille, J., & Hauser, P. M. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0901.020141 · Cited by 46
Durand-Joly, I., Soula, F., Chabé, M., Dalle, J., Lafitte, J. J., Sénéchal, M., Pinon, A., Camus, D., & Dei‐Cas, E. (2003) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2003.tb00650.x · Cited by 46
Sepkowitz, K. A. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.102 · Cited by 46
Immunopathogenesis of Pneumocystis carinii pneumonia
Gigliotti, F., & Wright, T. W. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399405010203 · Cited by 46
Barbounis, V., Aperis, G., Gambletsas, E., Koumakis, G., Demiris, M., Vassilomanolakis, M., & Efremidis, A. P. (2005) · PubMed · Cited by 44
Pneumocystis Workshop: 10th Anniversary Summary
Beck, J. M., & Cushion, M. T. (2009) · Eukaryotic Cell · doi:10.1128/ec.00309-08 · Cited by 42
Thomas, M., Rupali, P., Woodhouse, A. F., & Ellis-Pegler, R. B. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903214256 · Cited by 40
Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?
Moosig, F., Holle, J. U., & Gross, W. L. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2826 · Cited by 40
Cytokine profiles of bronchoalveolar lavage fluid in patients with pneumocystis pneumonia
Tasaka, S., Kobayashi, S., Kamata, H., Kimizuka, Y., Fujiwara, H., Funatsu, Y., Mizoguchi, K., Ishii, M., Takeuchi, T., & Hasegawa, N. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00229.x · Cited by 39
Self-citationThomas, S., Vivancos, R., Corless, C. E., Wood, G., Beeching, N. J., & Beadsworth, M. B. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir329 · Cited by 30
Escher, M., Stange, E., & Herrlinger, K. R. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.05.004 · Cited by 28
Kinetics of Serum .BETA.-D-Glucan after Pneumocystis Pneumonia Treatment in Patients with AIDS
Koga, M., Koibuchi, T., Kikuchi, T., Nakamura, H., Miura, T., Iwamoto, A., & Fujii, T. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5296 · Cited by 28
Louie, G. H., Wang, Z., & Ward, M. M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27735 · Cited by 28
Anand, S., Samaniego, M., & Kaul, D. R. (2011) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00692.x · Cited by 24
Okada, J., KADOYA, A., Rana, M., Ishikawa, A., Iikuni, Y., & Kondo, H. (1999) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi1970.73.1123 · Cited by 23
Itaba, S., Iwasa, T., Sadamoto, Y., Nasu, T., Misawa, T., Inoue, K., Shimokawa, H., Nakamura, K., & Takayanagi, R. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9575-5 · Cited by 18
[Clinical features of Pneumocystis pneumonia in patients with systemic lupus erythematosus].
Tasaka, S., Hasegawa, N., Yamada, W., Saito, F., Nishimura, T., & Ishizaka, A. (2006) · PubMed · Cited by 3
Self-citation
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“In addition, the increasing use of immunosuppressant drugs, their use in high doses or their combination has increased numbers of PCP cases in patients with solid tumours, haematological malignancies, rheumatic diseases or organ transplant recipients [128,129].”
BackgroundMethodPneumocystis jirovecii Pneumonia in Patients with or without AIDS, France
Roux, A., Canet, E., Valade, S., Gangneux-Robert, F., Hamane, S., Lafabrie, A., Maubon, D., Debourgogne, A., Le Gal, S., Dalle, F., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2009.131668 · Cited by 319
Kretchy, I. A., Asiedu-Danso, M., & Kretchy, J.-P. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.007 · Cited by 301
Cooley, L., Dendle, C., Wolf, J., Teh, B. W., Chen, S. C., Boutlis, C., & Thursky, K. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12599 · Cited by 228
Fauchier, T., Hasseine, L., Gari-Toussaint, M., Casanova, V., Marty, P., & Pomares-Estran, C. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03174-15 · Cited by 164
Metadata
- Authors
- Tasaka, S., & Tokuda, H.
- Affiliations
- Keio University (JP)
- Corresponding author
- Tasaka, Sadatomo
- Venue
- Journal of Infection and Chemotherapy
- Publisher
- Elsevier BV
- Published
- 2012
- Volume
- 18
- Issue
- 6
- Pages
- 793-806
- ISSN
- 1341-321X (ISSN-L)
- OpenAlex
- W2105078649
- Cited by
- 123
- References
- 119
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 10 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 9 · 2016: 19 · 2015: 13 · 2014: 17 · 2013: 4 · 2012: 1
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Infection and Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Pneumocystis carinii pneumonia, non-HIV immunocompromised patients, opportunistic infections, high-resolution computed tomography, PCR diagnosis, Pneumocystis colonization, asymptomatic carriers, chemoprophylaxis, organ transplantation, hematologic malignancies, connective tissue diseases, respiratory failure
- MeSH terms
- Humans, Immunocompetence, Immunosuppressive Agents, Pneumonia, Pneumocystis, HIV Infections, Communicable Diseases, Emerging, Pneumocystis carinii
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.